Tropical Diseases News and Research RSS Feed - Tropical Diseases News and Research

University of Oxford, SomaLogic partner to discover protein biomarkers for clinical diseases and conditions

University of Oxford, SomaLogic partner to discover protein biomarkers for clinical diseases and conditions

The University of Oxford and SomaLogic announced today that they have agreed to undertake a number of collaborative projects that will employ SomaLogic's proprietary SOMAmer reagents and SOMAscan assay technologies to discover and characterize protein biomarkers for a range of clinical diseases and conditions. [More]
Zika virus expected to spread across the U.S., says WHO

Zika virus expected to spread across the U.S., says WHO

On Monday (Jan. 25, 2016), the World Health Organization announced that Zika virus, a mosquito-borne illness that in the past year has swept quickly throughout equatorial countries, is expected to spread across the Americas and into the United States. [More]
Researchers take major step towards developing vaccine for river blindness

Researchers take major step towards developing vaccine for river blindness

The world's first vaccine for a disease that causes misery for millions in Africa could be tested within five years. [More]
Researchers use quick screening method to identify, test promising anti-Ebola drugs

Researchers use quick screening method to identify, test promising anti-Ebola drugs

A quick screening method has been used for the first time in a standard open laboratory to identify and test promising anti-Ebola drugs. This approach increases the possibility of finding new therapies faster. [More]
Areas stricken by extreme poverty more likely to be associated with high rates of Ebola transmission

Areas stricken by extreme poverty more likely to be associated with high rates of Ebola transmission

Since October 2014 the Ebola epidemic in West Africa has been diminishing and efforts have shifted from emergency response to prevention and mitigation of future outbreaks. Researchers from the Liberian Ministry of Health and the Yale Center for Infectious Disease Modelling and Analysis evaluated 3532 Ebola cases reported in 2014 in order to quantify the impact of poverty on the transmission and spread of Ebola. [More]
New funding supports research on new and improved drug treatments for tuberculosis, malaria

New funding supports research on new and improved drug treatments for tuberculosis, malaria

University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. [More]
Simple diagnostic test can help fight deadly sleeping sickness

Simple diagnostic test can help fight deadly sleeping sickness

Scientists have developed a quick and simple diagnosis method, similar to a dipstick pregnancy test, to fight a deadly sleeping sickness. [More]
Researchers set up citizen science program to gain insight into triatomine insects in Texas

Researchers set up citizen science program to gain insight into triatomine insects in Texas

Chagas disease is caused by a parasitic protozoan (Trypanosoma cruzi) and transmitted via triatomine insects known locally in Texas as "kissing bugs". Due to the success of community based triatomine surveillance and collection in Central and South America, researchers from Texas A & M University set up a citizen science program to gain insight into the distribution and infection prevalence of triatomine insects in Texas. [More]
WHO launches new comprehensive analysis of global health trends

WHO launches new comprehensive analysis of global health trends

The World Health Organization (WHO) today launched a new comprehensive analysis of global health trends since 2000 and an assessment of the challenges for the next 15 years. [More]
WHO recommends new strategies to treat HIV patients, reduce new infections

WHO recommends new strategies to treat HIV patients, reduce new infections

The world is poised to end the AIDS epidemic by 2030 – provided it can accelerate the pace of progress achieved globally over the past 15 years, according to a new World Health Organization (WHO) report. [More]
UTMB scientists work with InBios International to develop novel diagnostic test for chikungunya

UTMB scientists work with InBios International to develop novel diagnostic test for chikungunya

A novel and affordable diagnostic test for chikungunya will soon be available thanks to the work of researchers at the University of Texas Medical Branch at Galveston in partnership with a commercial lab. [More]

WHO report reveals significant reduction in TB deaths, but detection, treatment gaps still exist

The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to the World Health Organization’s Global Tuberculosis Report 2015, which was released today in Washington, DC. [More]
Snakebite claims thousands of lives every year but remains a 'forgotten killer'

Snakebite claims thousands of lives every year but remains a 'forgotten killer'

Snakebite claims thousands of lives in the world's poorest communities every year but remains a 'forgotten killer,' according to a new editorial published in the British Medical Journal. [More]

LSTM's health economists sketch out the importance for universal access to medicines

LSTM's health economists Professor Louis Niessen and Dr Jahangir Khan outline the importance for universal access to medicines in the control of neglected diseases, other major infections, and chronic diseases. [More]
Study reveals poor levels of use, availability and affordability of cardiovascular disease medicines worldwide

Study reveals poor levels of use, availability and affordability of cardiovascular disease medicines worldwide

New research published in The Lancet shows that the use of vital life-saving generic (and supposedly inexpensive) medicines for prevention in people with existing heart disease is poor worldwide. In low-income and middle-income countries these medicines are not widely available and, when available, can often be unaffordable. In rich countries, although such medicines are both available and affordable, 35% to 50% of patients who have heart disease or a previous stroke still do not receive them. [More]
Radical shift required in use of heart medicine worldwide

Radical shift required in use of heart medicine worldwide

Many people in the world who need essential heart medicine do not get it, even in rich countries, says new research published today in the medical journal The Lancet. [More]

New report finds tremendous opportunities for TB diagnostics in Brazil, China, India and South Africa

Brazil, China, India and South Africa, which together account for nearly half of all new tuberculosis (TB) cases, offer “tremendous opportunities” for new diagnostics due to their commitment to fight the disease at a time when investments in new technologies are on the increase, according to a new report from FIND, McGill International TB Centre, and UNITAID. [More]
Glycan binding proteins modify parasite infection in cells of the heart muscle

Glycan binding proteins modify parasite infection in cells of the heart muscle

Chagas disease is the main cause of infectious heart disease in Latin America. Researchers from the INGEBI and IBYME Institutes in Argentina explored the effect of glycan binding protein interactions between the human host and Typanosoma cruzi parasite. They found that a glycan binding protein expressed in humans modified the infection in cells of the heart muscle, showing the importance of galectins in the response to parasite infection. [More]

Nerve damage caused by leprosy linked to changes in the brain of patients

Brain plasticity is the ability of the brain to change both anatomically and functionally in response to changes in the body or in the environment. [More]
UC San Diego-led research team awarded $1.89 million to carry out research on leptospirosis

UC San Diego-led research team awarded $1.89 million to carry out research on leptospirosis

An international research team, headed by Joseph Vinetz, MD, professor of medicine at University of California, San Diego School of Medicine and director of the UC San Diego Center for Tropical Medicine and Travelers Health, has been awarded a 5-year, $1.89 million cooperative agreement to carry out translational research studies of leptospirosis, an infectious and sometimes fatal bacterial disease endemic in much of the world. [More]
Advertisement
Advertisement